📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Most Placebo-Controlled Trials in Inflammatory Bowel Disease were Underpowered Because of Overestimated Drug Efficacy Rates: Results from a Systematic Review of Induction Studies. (2023)

First Author: Bahnam P

Attributed to: Method - Analysis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/ecco-jcc/jjac150

PubMed Identifier: 36219564

Publication URI: http://europepmc.org/abstract/MED/36219564

Type: Journal Article/Review

Volume: 17

Parent Publication: Journal of Crohn's & colitis

Issue: 3

ISSN: 1873-9946